Cargando…

Granulocyte Macrophage Colony-Stimulating Factor–Activated CD39(+)/CD73(+) Murine Monocytes Modulate Intestinal Inflammation via Induction of Regulatory T Cells

BACKGROUND & AIMS: Granulocyte macrophage colony-stimulating factor (GM-CSF) treatment induces clinical response in patients with active Crohn’s disease. To explore whether monocytes mediate GM-CSF effects in vivo, we used a mouse model of chronic colitis induced by dextran sulfate sodium (DSS)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinhage, Toni, Däbritz, Jan, Brockhausen, Anne, Wirth, Timo, Brückner, Markus, Belz, Michael, Foell, Dirk, Varga, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301274/ https://www.ncbi.nlm.nih.gov/pubmed/28210690 http://dx.doi.org/10.1016/j.jcmgh.2015.04.005

Ejemplares similares

Peripheral Monocyte Functions and Activation in Patients with Quiescent Crohn’s Disease
por: Schwarzmaier, David, et al.
Publicado: (2013)

Myeloid regulatory cells: cross talk of innate and adaptive immunity to maintain the intestinal immune homeostasis in inflammatory bowel disease
por: Däbritz, Jan, et al.
Publicado: (2015)

PReS-FINAL-2332: Activation-induced cell death of human monocytes as a novel mechanism fine-tuning inflammation and autoimmunity
por: Miranda-García, M, et al.
Publicado: (2013)

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
por: Crooke, Almudena, et al.
Publicado: (2017)

Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
por: Goueli, Said A., et al.
Publicado: (2019)

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
por: Schäkel, Laura, et al.
Publicado: (2020)

Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells
por: Fakhimi, Maryam, et al.
Publicado: (2020)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Aliagas, Elisabet, et al.
Publicado: (2014)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

PReS-FINAL-2182: The role of murine rage in innate immune responses and inflammation: a systematic approach
por: Wirth, T, et al.
Publicado: (2013)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
por: Deaglio, Silvia, et al.
Publicado: (2007)

The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain
por: Matyash, Marina, et al.
Publicado: (2017)

PW03-031 – Activation-induced cell death of human monocytes
por: Miranda-Garcia, M, et al.
Publicado: (2013)

CD73 Is Critical for the Resolution of Murine Colonic Inflammation
por: Bynoe, Margaret S., et al.
Publicado: (2012)

Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 after Ischemic Injury
por: Bönner, Florian, et al.
Publicado: (2012)

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
por: Horenstein, Alberto L., et al.
Publicado: (2018)

CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease
por: Kudryavtsev, Igor, et al.
Publicado: (2019)

Relationship between the Gene Expression of Adenosine Kinase Isoforms and the Expression of CD39 and CD73 Ectonucleotidases in Colorectal Cancer
por: Zhulai, G. A., et al.
Publicado: (2023)

CD73 Dysregulates Monocyte Anti-Tumor Activity in Multiple Myeloma
por: Zhou, Lin, et al.
Publicado: (2023)

The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice
por: Weinhage, Toni, et al.
Publicado: (2020)

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
por: Horenstein, Alberto L, et al.
Publicado: (2013)

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4(+) CD25(high)Foxp3(+) regulatory T‐cells in psoriasis
por: Han, Ling, et al.
Publicado: (2017)

Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over
por: Kling, Lovis, et al.
Publicado: (2017)

Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021)

Differential Regulation of CD45 Expression on Granulocytes, Lymphocytes, and Monocytes in COVID-19
por: Ahmed, Muhammad G. T., et al.
Publicado: (2022)

Comparison of the expression of cluster of differentiation (CD)39 and CD73 between propofol- and sevoflurane-based anaesthesia during open heart surgery
por: Oh, Chung-Sik, et al.
Publicado: (2018)

Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
por: Muñóz-Godínez, Ricardo, et al.
Publicado: (2020)

Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B
por: Zhou, Shuang-Nan, et al.
Publicado: (2020)

The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
por: Bauer, Arthur, et al.
Publicado: (2022)

Clinical implications of Golgi protein 73 and granulocyte colony-stimulating factor and their related factors in children with bronchopneumonia
por: Li, Baofa, et al.
Publicado: (2022)

Functional characterization of GM-CSF induced monocyte subsets
por: Däbritz, J, et al.
Publicado: (2008)

Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8(+) T Cells in a Tissue-Dependent Manner and Can Inhibit T Cell Responses to Stimulation
por: Smith, Corinne J., et al.
Publicado: (2021)

HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1
por: de Lourdes Mora-García, María, et al.
Publicado: (2019)

CD39/CD73 Dysregulation of Adenosine Metabolism Increases Decidual Natural Killer Cell Cytotoxicity: Implications in Unexplained Recurrent Spontaneous Abortion
por: Zhu, Jianan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vocgqbqs9sk4diles6ehnqk9f